Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GKOS NYSE:INSP NASDAQ:IRTC NASDAQ:MMSI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGKOSGlaukos$120.95-13.0%$120.19$73.16▼$148.11$8.17B0.94896,120 shs2.71 million shsINSPInspire Medical Systems$43.79-2.1%$51.61$39.61▼$147.66$1.26B0.831.39 million shs1.38 million shsIRTCiRhythm Technologies$116.56-1.1%$118.92$108.81▼$212.00$3.83B1.33580,839 shs462,964 shsMMSIMerit Medical Systems$64.17+0.8%$66.86$59.74▼$97.18$3.80B0.58938,690 shs449,465 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGKOSGlaukos-12.98%-15.73%-0.55%+0.45%+27.34%INSPInspire Medical Systems-2.28%+9.36%-18.94%-26.42%-70.08%IRTCiRhythm Technologies-1.11%+2.25%-4.42%-22.79%-16.67%MMSIMerit Medical Systems+0.85%+4.58%-7.96%-21.94%-33.50%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGKOSGlaukos$120.95-13.0%$120.19$73.16▼$148.11$8.17B0.94896,120 shs2.71 million shsINSPInspire Medical Systems$43.79-2.1%$51.61$39.61▼$147.66$1.26B0.831.39 million shs1.38 million shsIRTCiRhythm Technologies$116.56-1.1%$118.92$108.81▼$212.00$3.83B1.33580,839 shs462,964 shsMMSIMerit Medical Systems$64.17+0.8%$66.86$59.74▼$97.18$3.80B0.58938,690 shs449,465 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGKOSGlaukos-12.98%-15.73%-0.55%+0.45%+27.34%INSPInspire Medical Systems-2.28%+9.36%-18.94%-26.42%-70.08%IRTCiRhythm Technologies-1.11%+2.25%-4.42%-22.79%-16.67%MMSIMerit Medical Systems+0.85%+4.58%-7.96%-21.94%-33.50%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGKOSGlaukos 2.86Moderate Buy$146.1720.85% UpsideINSPInspire Medical Systems 2.05Hold$81.8486.88% UpsideIRTCiRhythm Technologies 2.93Moderate Buy$191.8564.59% UpsideMMSIMerit Medical Systems 2.64Moderate Buy$92.8044.62% UpsideCurrent Analyst Ratings BreakdownLatest GKOS, IRTC, MMSI, and INSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026INSPInspire Medical Systems Summit RedstoneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$39.005/22/2026INSPInspire Medical Systems Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeNeutral ➝ Underperform$39.005/21/2026GKOSGlaukos BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$141.00 ➝ $162.005/18/2026IRTCiRhythm Technologies Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$225.00 ➝ $180.005/13/2026INSPInspire Medical Systems Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/8/2026MMSIMerit Medical Systems Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/7/2026INSPInspire Medical Systems OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Perform5/6/2026INSPInspire Medical Systems Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/5/2026INSPInspire Medical Systems Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$56.00 ➝ $45.005/5/2026INSPInspire Medical Systems EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$55.005/5/2026INSPInspire Medical Systems Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Neutral$85.00 ➝ $55.00(Data available from 5/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGKOSGlaukos$507.44M14.00N/AN/A$11.42 per share10.59INSPInspire Medical Systems$915.25M1.38$2.80 per share15.62$27.50 per share1.59IRTCiRhythm Technologies$787.85M4.86N/AN/A$4.91 per share23.74MMSIMerit Medical Systems$1.54B2.48$5.93 per share10.82$27.27 per share2.35Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGKOSGlaukos-$187.69M-$3.28N/A257.34N/A-34.34%-6.92%-5.25%7/29/2026 (Estimated)INSPInspire Medical Systems$145.42M$4.499.7529.794.6214.33%10.35%8.81%8/3/2026 (Estimated)IRTCiRhythm Technologies-$44.55M-$0.86N/A88.98N/A-3.53%-10.26%-1.39%7/30/2026 (Estimated)MMSIMerit Medical Systems$128.49M$2.3127.7816.291.989.03%13.54%7.94%7/29/2026 (Estimated)Latest GKOS, IRTC, MMSI, and INSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/4/2026Q1 2026INSPInspire Medical Systems-$0.2753$0.10+$0.3753-$0.39$200.04 million$204.58 million4/30/2026Q1 2026IRTCiRhythm Technologies-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 million4/30/2026Q1 2026MMSIMerit Medical Systems$0.84$0.94+$0.10$0.68$377.59 million$381.88 million4/29/2026Q1 2026GKOSGlaukos-$0.30-$0.18+$0.12-$0.34$137.00 million$150.57 million2/24/2026Q4 2025MMSIMerit Medical Systems$0.96$1.04+$0.08$0.63$390.77 million$393.94 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGKOSGlaukosN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/AMMSIMerit Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGKOSGlaukos0.105.434.73INSPInspire Medical SystemsN/A6.344.48IRTCiRhythm Technologies4.035.174.98MMSIMerit Medical Systems0.455.083.46Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGKOSGlaukos99.04%INSPInspire Medical Systems94.91%IRTCiRhythm TechnologiesN/AMMSIMerit Medical Systems99.66%Insider OwnershipCompanyInsider OwnershipGKOSGlaukos5.90%INSPInspire Medical Systems2.20%IRTCiRhythm Technologies0.98%MMSIMerit Medical Systems0.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGKOSGlaukos1,09458.73 million55.27 millionOptionableINSPInspire Medical Systems1,33328.81 million28.18 millionOptionableIRTCiRhythm Technologies2,40032.86 million32.54 millionOptionableMMSIMerit Medical Systems7,50059.66 million59.24 millionOptionableGKOS, IRTC, MMSI, and INSP HeadlinesRecent News About These CompaniesMerit Medical Systems, Inc. $MMSI Stake Reduced by Handelsbanken Fonder ABMay 21 at 5:14 AM | marketbeat.comMerit Medical Updates Governance and Elects New DirectorMay 19, 2026 | tipranks.comMerit Medical Systems Elects Scott R. Ward to Board of DirectorsMay 19, 2026 | quiverquant.comQMerit Medical Shareholders Elect Scott R. Ward to Board of DirectorsMay 19, 2026 | globenewswire.comBessemer Group Inc. Buys 110,392 Shares of Merit Medical Systems, Inc. $MMSIMay 17, 2026 | marketbeat.comThrivent Financial for Lutherans Sells 17,162 Shares of Merit Medical Systems, Inc. $MMSIMay 16, 2026 | marketbeat.comHow Investors May Respond To Merit Medical Systems (MMSI) Q1 Beat And Raised 2026 Revenue GuidanceMay 14, 2026 | finance.yahoo.comMerit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12, 2026 | seekingalpha.comBrian Lloyd Buys 2,000 Shares of Merit Medical Systems (NASDAQ:MMSI) StockMay 12, 2026 | insidertrades.comMerit Medical Systems (NASDAQ:MMSI) Director Lynne Ward Sells 5,000 SharesMay 12, 2026 | americanbankingnews.comInsider Shake-Up at Merit Medical Systems as Top Executives Trade SharesMay 11, 2026 | tipranks.comBrian Lloyd Acquires 2,000 Shares of Merit Medical Systems (NASDAQ:MMSI) StockMay 11, 2026 | marketbeat.comMerit Medical Systems (NASDAQ:MMSI) Director Sells $313,050.00 in StockMay 11, 2026 | marketbeat.comMerit Medical to Participate in the Bank of America Healthcare ConferenceMay 8, 2026 | globenewswire.comThe Top 5 Analyst Questions From Merit Medical Systems’s Q1 Earnings CallMay 7, 2026 | msn.comWhy Merit Medical (MMSI) is a top value stock for the long termMay 5, 2026 | msn.comWhy Merit Medical (MMSI) is a Top Value Stock for the Long-TermMay 5, 2026 | zacks.comVanguard Group Inc. Sells 61,420 Shares of Merit Medical Systems, Inc. $MMSIMay 5, 2026 | marketbeat.comMerit Medical Systems, Inc. 2026 Q1 - Results - Earnings Call PresentationMay 4, 2026 | seekingalpha.comWhy Merit Medical Systems, Inc.’s (MMSI) Stock Is Down 5.54%May 4, 2026 | aaii.comAMerit Medical Systems (NASDAQ:MMSI) Reaches New 12-Month Low Following Analyst DowngradeMay 4, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGKOS, IRTC, MMSI, and INSP Company DescriptionsGlaukos NYSE:GKOS$120.95 -18.08 (-13.00%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$119.97 -0.98 (-0.81%) As of 05/22/2026 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.Inspire Medical Systems NYSE:INSP$43.79 -0.95 (-2.11%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$43.81 +0.01 (+0.03%) As of 05/22/2026 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.iRhythm Technologies NASDAQ:IRTC$116.56 -1.31 (-1.11%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$116.55 -0.01 (-0.01%) As of 05/22/2026 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Merit Medical Systems NASDAQ:MMSI$64.17 +0.54 (+0.85%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$64.17 +0.00 (+0.01%) As of 05/22/2026 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
